Inscription à l’infolettre

Publications

Publications récentes

Voir les publications précédentes
  • 28 décembre 2024

    PP2A-Tws dephosphorylates Map205, is required for Polo localization to microtubules and promotes cytokinesis in Drosophila.

    Guelle M, Emond-Fraser V, Archambault V
    Cell Div 2024-12-28 ;19( 1 ):36

  • 18 décembre 2024

    Correction: Regulation of the DNA Damage Response and Gene Expression by the Dot1L Histone Methyltransferase and the 53Bp1 Tumour Suppressor.

    FitzGerald J, Moureau S, Drogaris P, O'Connell E, Abshiru N, Verreault A, Thibault P, Grenon M, Lowndes NF
    PLoS One 2024-12-18 ;19( 12 ):e0316233

  • 29 novembre 2024

    Tracking the gene expression programs and clonal relationships that underlie mast, myeloid, and T lineage specification from stem cells.

    Michaels YS, Major MC, Bonham-Carter B, Zhang J, Heydari T, Edgar JM, Siu MM, Greenstreet L, Vilarrasa-Blasi R, Kim S, Castle EL, Forrow A, Ibanez-Rios MI, Zimmerman C, Chung Y, Stach T, Werschler N, Knapp D, Vento-Tormo R, Schiebinger G, Zandstra PW
    Cell Syst 2024-11-29 ;15( 12 ):1245-1263.e10

  • 28 novembre 2024

    Machine learning-enhanced immunopeptidomics applied to T-cell epitope discovery for COVID-19 vaccines.

    Kovalchik KA, Hamelin DJ, Kubiniok P, Bourdin B, Mostefai F, Poujol R, Paré B, Simpson SM, Sidney J, Bonneil E, Courcelles M, Saini SK, Shahbazy M, Kapoor S, Rajesh V, Weitzen M, Grenier JC, Gharsallaoui B, Maréchal L, Wu Z, Savoie C, Sette A, Thibault P, Sirois I, Smith M, Decaluwe H, Hussin JG, Lavallée-Adam M, Caron E
    Nat Commun 2024-11-28 ;15( 1 ):10316

  • 26 novembre 2024

    UM171 enhances fitness and engraftment of gene-modified hematopoietic stem cells from patients with sickle cell disease.

    Liu B, Klatt D, Zhou Y, Manis JP, Sauvageau G, Pellin D, Brendel C, Williams DA
    Blood Adv 2024-11-26 ;8( 22 ):5885-5895

  • 23 novembre 2024

    The cell adhesion molecule CD44 acts as a modulator of 5-HT7 receptor functions.

    Borsdorf S, Zeug A, Wu Y, Mitroshina E, Vedunova M, Gaitonde SA, Bouvier M, Wehr MC, Labus J, Ponimaskin E
    Cell Commun Signal 2024-11-23 ;22( 1 ):563

  • 16 novembre 2024

    A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant.

    LeBlanc R, Thiant S, Terra R, Ahmad I, Claveau JS, Bambace N, Bernard L, Cohen S, Delisle JS, Lachance S, Kiss T, Roy DC, Sauvageau G, Roy J
    Curr Oncol 2024-11-16 ;31( 11 ):7258-7274

  • 29 octobre 2024

    Comparative small molecule screening of primary human acute leukemias, engineered human leukemia and leukemia cell lines.

    Safa-Tahar-Henni S, Páez Martinez K, Gress V, Esparza N, Roques E, Bonnet-Magnaval F, Bilodeau M, Gagné V, Bresson E, Cardin S, El-Hachem N, Iasenza I, Alzial G, Boivin I, Nakamichi N, Soufflet AC, Mirela Pascariu C, Duchaine J, Mathien S, Bonneil E, Eppert K, Marinier A, Sauvageau G, Deblois G, Thibault P, Hébert J, Eaves CJ, Cellot S, Barabé F, Wilhelm B
    Leukemia 2024-10-29 ;39( 1 ):29-41

Voir plus de publications